Items tagged with Diagnostics
Improving TB diagnosis: USAID performance evaluation of the TB CARE medical specimen transport system in Zimbabwe (post)
25 March 2015 - Zimbabwe - Zimbabwe is among 22 countries worldwide designated as high burden countries (HBCs) for tuberculosis, with an estimated incidence of 552 per hundred thousand population. Case detection rates fall below international targets, estimated at about 45%. As part of efforts to improve TB diagnosis, the Zimbabwe National TB Control Programme (NTP) has identified a strategic need to strengthen referral networks and transport logistics between peripheral health facilities and laboratories.
Blood-based biomarkers could enable simple, accurate TB tests for diagnosis and monitoring (post)
Researchers have identified blood-based biomarkers in patients with active tuberculosis (ATB) that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure.
Seattle startup AttoDx wins NIH funds for ultrasensitive TB MDx (post)
NEW YORK (GenomeWeb) – Start-up diagnostics firm AttoDx has been awarded National Institutes of Health funds to develop an ultrasensitive molecular diagnostic for difficult-to-detect cases of tuberculosis.
Indian approval of import licence for Genedrive® TB molecular diagnostic test (post)
MANCHESTER, UNITED KINGDOM, April 23, 2015) - Epistem Holdings Plc (LSE:EHP), the personalised medicine and biotechnology company, announces today that the Drug Controller General of India (DCGI), Ministry of Health and family Welfare, Government of India has issued an import licence to its Indian distribution partner, Xcelris Labs, for the import of Epistem's tuberculosis (TB) and antibiotic resistance test. The licence, which has been granted for a period of three years, enables Xcelris Labs to import Epistem's new molecular test subject to normal conditions for such a product. Epistem and Xcelris Labs will now commence the process of preparing for the launch of Genedrive® and the TB and antibiotic resistance test into the Indian and Indian-sub continent markets.
Costs and consequences of using interferon-γ release assays for the diagnosis of active tuberculosis in India (post)
Abstract
A sensitive urinary lipoarabinomannan test for tuberculosis (post)
Abstract
New test could identify resistant tuberculosis faster (post)
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
Tuberculosis testing market estimated to expand by 2020 (post)
Experts from Transparency Market Research have recently estimated that the worldwide tuberculosis (TB) testing market will reach $2,619.4 million (USD) by the year 2020.
Page 8 of 70 · Total posts: 0
←First 7 8 9 Last→